Authors:
Laban, U
Kurrasch-Orbaugh, D
Marona-Lewicka, D
Nichols, DE
Citation: U. Laban et al., A novel fluorinated tryptamine with highly potent serotonin 5-HT1A receptor agonist properties, BIOORG MED, 11(6), 2001, pp. 793-795
Authors:
Tian, FF
Chang, CJ
Grutzner, JB
Nichols, DE
McLaughlin, JL
Citation: Ff. Tian et al., Robinlin: A novel bioactive homo-monoterpene from Robinia pseudoacacia L. (Fabaceae), BIOORG MED, 11(19), 2001, pp. 2603-2606
Authors:
Sprague, JE
Worst, TJ
Haynes, K
Mosler, CR
Nichols, DE
Kane, MD
Citation: Je. Sprague et al., The pharmacodynamic characterization of an antisense oligonucleotide against monoamine oxidase-B (MAO-B) in rat brain striatal tissue, CELL MOL N, 21(1), 2001, pp. 53-64
Citation: T. Sattelkau et al., An efficient synthesis of the potent dopamine D-1 agonist dinapsoline by construction and selective reduction of 2 '-azadimethoxybenzanthrone, SYNTHESIS-S, (2), 2001, pp. 262-266
Authors:
Gulwadi, AG
Korpinen, CD
Mailman, RB
Nichols, DE
Sit, SY
Taber, MT
Citation: Ag. Gulwadi et al., Dinapsoline: Characterization of a D-1 dopamine receptor agonist in a rat model of Parkinson's disease, J PHARM EXP, 296(2), 2001, pp. 338-344
Authors:
Chambers, JJ
Kurrasch-Orbaugh, DM
Parker, MA
Nichols, DE
Citation: Jj. Chambers et al., Enantiospecific synthesis and pharmacological evaluation of a series of super-potent, conformationally restricted 5-HT2A/2C receptor agonists, J MED CHEM, 44(6), 2001, pp. 1003-1010
Citation: De. Nichols et S. Frescas, Improvements to the synthesis of psilocybin and a facile method for preparing the O-acetyl prodrug of psilocin, SYNTHESIS-S, (6), 1999, pp. 935-938
Authors:
Scorza, C
Silveira, R
Nichols, DE
Reyes-Parada, M
Citation: C. Scorza et al., Effects of 5-HT-releasing agents on the extracellullar hippocampal 5-HT ofrats. Implications for the development of novel antidepressants with a short onset of action, NEUROPHARM, 38(7), 1999, pp. 1055-1061
Citation: Am. Qandil et al., Alternative formal synthesis of the potent D-1 dopamine agonist dihydroxy-2,3,7,11b-tetrahydro-1H-naphth[1,2,3-de]isoquinoline: Dinapsoline, J ORG CHEM, 64(4), 1999, pp. 1407-1409
Authors:
Blair, JB
Marona-Lewicka, D
Kanthasamy, A
Lucaites, VL
Nelson, DL
Nichols, DE
Citation: Jb. Blair et al., Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine, J MED CHEM, 42(6), 1999, pp. 1106-1111
Authors:
Doll, MKH
Nichols, DE
Kilts, JD
Prioleau, C
Lawler, CP
Lewis, MM
Mailman, RB
Citation: Mkh. Doll et al., Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quinelorane, J MED CHEM, 42(5), 1999, pp. 935-940
Authors:
Gerasimov, M
Marona-Lewicka, D
Kurrasch-Orbaugh, DM
Qandil, AM
Nichols, DE
Citation: M. Gerasimov et al., Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain, J MED CHEM, 42(20), 1999, pp. 4257-4263
Authors:
Hoffman, B
Cho, SJ
Zheng, WF
Wyrick, S
Nichols, DE
Mailman, RB
Tropsha, A
Citation: B. Hoffman et al., Quantitative structure-activity relationship modeling of dopamine D-1 antagonists using comparative molecular field analysis, genetic algorithms-partial least-squares, and K nearest neighbor methods, J MED CHEM, 42(17), 1999, pp. 3217-3226
Authors:
Parker, MA
Marona-Lewicka, D
Lucaites, VL
Nelson, DL
Nichols, DE
Citation: Ma. Parker et al., A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor, J MED CHEM, 41(26), 1998, pp. 5148-5149
Authors:
Vangveravong, S
Kanthasamy, A
Lucaites, VL
Nelson, DL
Nichols, DE
Citation: S. Vangveravong et al., Synthesis and serotonin receptor affinities of a series of trans-2-(indol-3-yl)cyclopropylamine derivatives, J MED CHEM, 41(25), 1998, pp. 4995-5001